Mitochondrial abnormalities in neurological disorders (2021)
- Authors:
- USP affiliated authors: BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; FERREIRA, ANA FLAVIA FERNANDES - ICB ; SINGULANI, MONIQUE PATRICIO - FM
- Unidades: ICB; FM
- DOI: 10.1016/B978-0-12-822416-8.00012-9
- Subjects: MITOCÔNDRIAS; METABOLISMO CELULAR; DOENÇAS DO SISTEMA NERVOSO CENTRAL
- Language: Inglês
- Imprenta:
- Publisher: Esevier All Inc.
- Publisher place: Amsterdam
- Date published: 2021
- Source:
- Título: Mithocondrial metabolism
- Volume/Número/Paginação/Ano: 316 p.
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FERREIRA, Ana Flávia Fernandes e SINGULANI, Monique Patricio e BRITTO, Luiz Roberto Giorgetti de. Mitochondrial abnormalities in neurological disorders. Mithocondrial metabolism. Tradução . Amsterdam: Esevier All Inc., 2021. p. 316 . Disponível em: https://doi.org/10.1016/B978-0-12-822416-8.00012-9. Acesso em: 29 jan. 2026. -
APA
Ferreira, A. F. F., Singulani, M. P., & Britto, L. R. G. de. (2021). Mitochondrial abnormalities in neurological disorders. In Mithocondrial metabolism (p. 316 ). Amsterdam: Esevier All Inc. doi:10.1016/B978-0-12-822416-8.00012-9 -
NLM
Ferreira AFF, Singulani MP, Britto LRG de. Mitochondrial abnormalities in neurological disorders [Internet]. In: Mithocondrial metabolism. Amsterdam: Esevier All Inc.; 2021. p. 316 .[citado 2026 jan. 29 ] Available from: https://doi.org/10.1016/B978-0-12-822416-8.00012-9 -
Vancouver
Ferreira AFF, Singulani MP, Britto LRG de. Mitochondrial abnormalities in neurological disorders [Internet]. In: Mithocondrial metabolism. Amsterdam: Esevier All Inc.; 2021. p. 316 .[citado 2026 jan. 29 ] Available from: https://doi.org/10.1016/B978-0-12-822416-8.00012-9 - Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease
- Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model
- Neuroplasticity induced by the retention period of a complex motor skill learning in rats
- Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model
- The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Análise da biogênese e disfunção mitocondrial na progressão da doença de Alzheimer em camundongos 3xTg-AD
- The role of interleukin-17 in neurological disorders
- Lithium and disease modification: a systematic review and meta-analysis in Alzheimer's and Parkinson’s disease
- Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model
- Deletion of the transient receptor potential melastatin 2 gene mitigates the 6-hyydroxydopamine-induced Parkinson’s Disease–Like Pathology
Informações sobre o DOI: 10.1016/B978-0-12-822416-8.00012-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
